National Match Code: TBD

PGY2 Oncology Program Director
Michelle Te Ronde, PharmD
Telephone: 414-805-6575
Fax: 262-532-3222
E-mail: [email protected]

Duration/Type: 12-month residency
Number of Positions: 1
Application Deadline: Jan. 2, 2024
Starting Date: July 1, 2024
Stipend: $53,040

The purpose of this PGY2 pharmacy residency program is to build on Doctor of Pharmacy (Pharm.D.) education and PGY1 pharmacy residency programs to contribute to the development of clinical pharmacists in specialized areas of practice. PGY2 residencies provide residents with opportunities to function independently as practitioners by conceptualizing and integrating accumulated experience and knowledge and incorporating both into the provision of patient care or other advanced practice settings. Residents who successfully complete an accredited PGY2 pharmacy residency are prepared for advanced patient care, academic or other specialized positions, along with board certification, if available.


This 12-month residency program is designed to prepare the graduate for an advanced role in thrombosis and hemostasis clinical settings including anticoagulation and hemostasis consult services, outpatient anticoagulation management services, or anticoagulation and hemostasis stewardship program as well as a leadership or faculty member role. Residents will complete research projects, a service development project and teaching activities that are tailored to meet the needs and interests of the resident. Residents will have the opportunity to precept PGY1 residents and PharmD students on clinical rotation. The residency program has a biweekly education seminar with other THM residency sites across the country to provide additional learning and presenting opportunities, networking and professional development.

The program is affiliated with the Medical College of Wisconsin, which provides residents with teaching opportunities in didactic and experiential settings. An optional teaching certificate is available. Residents will have opportunities to precept and take an active role in layered learning within the organization. Research projects, service development, and teaching activities are tailored to align with the needs and interests of the PGY2 resident.

Requirements for Acceptance

  • Completion of ASHP Accredited PGY1 pharmacy residency
  • Applicants are required to submit a program application through PhORCAS. Please follow the application instructions.
  • Responses to the following supplemental application questions should be submitted through PhORCAS in place of a letter of intent.
    • Describe your pharmacy experiences to date and how they have shaped your desire to pursue residency training with a focus in ambulatory care.
    • Besides the general goals of board certification and preceptorship, please discuss your short and long-term career goals.
    • What characteristics are you looking for in a residency program? How does Froedtert’s PGY2 Thrombosis and Hemostasis Residency Program meet your criteria?
    • What are your goals for your PGY2 residency year?
    • Describe a significant personal challenge you have faced, one that you feel has shaped you as a person. Please include how you got through the experience and what you learned about yourself as a result.
    • What do you expect your greatest challenge to be during residency?

Learning Experiences

Required Rotations

  • Orientation
  • Anticoagulation Management Service
  • Benign Hematology
  • Cardiac Surgery
  • Emergency Medicine (ED) or Cardiology
  • Leadership
  • Perioperative Care
  • Stewardship and Hematology Lab
  • Comprehensive Center for Blood Disorders (CCBD) Versiti (Longitudinal)

Elective Rotations

  • Academia
    • Medical College of Wisconsin
    • Concordia University
  • Advanced Heart Failure (AHF)
  • Anemia*
  • Cardiology**
  • Cardiology/ Heart Failure*
  • Emergency Department**
  • Internal Medicine**
  • Medication Safety
  • Metabolic Syndrome Clinic
  • Neuro ICU/ Neurosurgery**
  • Pharmacogenomics
  • Solid Organ Transplant/ TICU**
  • Surgical ICU**
  • Transplant Clinic* (only available to residents who will complete the TICU rotation during the residency year)

*Required to choose one Ambulatory elective
**Required to choose two Acute Care electives

Requirements and Expectations

The following are some of the requirements and expectations for participants in the PGY2 Thrombosis and Hemostasis Residency at Froedtert Hospital.

TRAIN Pharmacy Seminar Series

  • Virtual seminar series moderated by staff from each of the AC Forum PGY2 Residency sites

Drug Policy, Medication Safety and Committee Responsibilities

  • Attend Antithrombotic Therapy Management Program
  • Attend Hematology Lab Meetings
  • Attend Benign Hematology Meetings
  • Attend Froedtert Health Pharmacy and Therapeutics Committee

Conference Attendance

  • AC Forum Biennial National Conference- (required)
  • Vizient and ASHP Clinical Midyear (optional)
  • Wisconsin Pharmacy Residency Conference (required)

Presentation Requirements

  • Research projects
    • Poster and platform presentation
  • Completion of manuscript suitable for publication

Staffing Responsibilities

  • Residents staff in Anticoagulation Clinic (AMS) as assigned
  • Staff one 10 hour shift per week
  • Approximately 20 additional staffing shifts scheduled during the residency year
  • Staff up to ten (10) “sick call pulls” during the year

*Additional activities may be required based on project and rotation selection. Satisfactory completion of the above list is intended as a minimum to earn a Froedtert Hospital residency certificate.


Please contact our pharmacy residency program directors with any questions or concerns you may have.

Froedtert & MCW Pharmacy Residency Programs Diversity Statement

The Froedtert & MCW Pharmacy Residency Program is committed to recruiting and training pharmacists from diverse backgrounds and experiences. We value the different perspectives each resident offers. In training pharmacists as one of the most accessible members on the health care team, a diverse workforce is essential to advance the health of the patients we serve.